Evidence map›Paper›PMID 42052449›Full record

ArticleFrontiers in oncology2026

Clear cell renal cell carcinoma metastasizing to the thyroid gland: a case report.

Zhengshi Xia, Zuzhi Zhao, Peng Sun, Pengfei Xu, Jianhua Li

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhengshi XiaDepartment of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Zuzhi ZhaoDepartment of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Peng SunDepartment of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Pengfei XuDepartment of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Jianhua LiDepartment of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic tumors of the thyroid gland are rare in clinical practice. Clear cell renal cell carcinoma (ccRCC) is the most common primary site among metastatic thyroid carcinomas, accounting for 12% to 34% of all secondary thyroid tumors. Most secondary thyroid cancers have a poorer prognosis than primary papillary thyroid carcinoma. Therefore, the diagnosis and treatment of secondary thyroid tumors deserve attention. The diagnosis and treatment of secondary thyroid carcinoma pose significant challenges. We herein report a case of clear cell renal cell carcinoma metastasizing to the thyroid gland.

Indexed as

case reportclear cell carcinomametastasis (cancer metastasis)renal cell carcinomathyroid metastasis

Identifiers

PMID42052449
PMCPMC13111031

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.